skip to main content
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: Annals Of Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Early evolutionary divergence between papillary and anaplastic thyroid cancers
Material Type:
Artigo
Adicionar ao Meu Espaço

Early evolutionary divergence between papillary and anaplastic thyroid cancers

Capdevila, J. ; Mayor, R. ; Mancuso, F.M. ; Iglesias, C. ; Caratù, G. ; Matos, I. ; Zafón, C. ; Hernando, J. ; Petit, A. ; Nuciforo, P. ; Cameselle-Teijeiro, J.M. ; Álvarez, C. ; Recio, J.A. ; Tabernero, J. ; Matias-Guiu, X. ; Vivancos, A. ; Seoane, J.

Annals of oncology, 2018-06, Vol.29 (6), p.1454-1460 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

2
Antitumor activity of lurbinectedin (PM01183) and doxorubicin in relapsed small-cell lung cancer: results from a phase I study
Material Type:
Artigo
Adicionar ao Meu Espaço

Antitumor activity of lurbinectedin (PM01183) and doxorubicin in relapsed small-cell lung cancer: results from a phase I study

Calvo, E. ; Moreno, V. ; Flynn, M. ; Holgado, E. ; Olmedo, M.E. ; Lopez Criado, M.P. ; Kahatt, C. ; Lopez-Vilariño, J.A. ; Siguero, M. ; Fernandez-Teruel, C. ; Cullell-Young, M. ; Soto Matos-Pita, A. ; Forster, M.

Annals of oncology, 2017-10, Vol.28 (10), p.2559-2566 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

3
Immunotherapy in organ-transplanted cancer patients: efficacy and risk of organ rejection
Material Type:
Artigo
Adicionar ao Meu Espaço

Immunotherapy in organ-transplanted cancer patients: efficacy and risk of organ rejection

Ros, J. ; Matos, I. ; Martin-Liberal, J.

Annals of oncology, 2019-07, Vol.30 (7), p.1173-1177 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

4
Early evolutionary divergence between papillary and anaplastic thyroid cancers
Material Type:
Artigo
Adicionar ao Meu Espaço

Early evolutionary divergence between papillary and anaplastic thyroid cancers

Capdevila, J. ; Mayor, R. ; Mancuso, F.M. ; Iglesias, C. ; Caratú, G. ; Matos, I. ; Zafón, C. ; Hernando, J. ; Petit, A. ; Nuciforo, P. ; Cameselle-Teijeiro, J.M. ; Álvarez, C.V. ; Recio, J.A. ; Tabernero, J. ; Matias-Guiu, X. ; Vivancos, A. ; Seoane, J.

Annals of oncology, 2019-11, Vol.30 (11), p.1843-1843 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

5
Effect of BRCA1 and XPG mutations on treatment response to trabectedin and pegylated liposomal doxorubicin in patients with advanced ovarian cancer: exploratory analysis of the phase 3 OVA-301 study
Material Type:
Artigo
Adicionar ao Meu Espaço

Effect of BRCA1 and XPG mutations on treatment response to trabectedin and pegylated liposomal doxorubicin in patients with advanced ovarian cancer: exploratory analysis of the phase 3 OVA-301 study

Monk, B.J. ; Ghatage, P. ; Parekh, T. ; Henitz, E. ; Knoblauch, R. ; Matos-Pita, A.S. ; Nieto, A. ; Park, Y.C. ; Cheng, P.S. ; Li, W. ; Favis, R. ; Ricci, D. ; Poveda, A.

Annals of oncology, 2015-05, Vol.26 (5), p.914-920 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

6
Early-drug development in the era of immuno-oncology: are we ready to face the challenges?
Material Type:
Artigo
Adicionar ao Meu Espaço

Early-drug development in the era of immuno-oncology: are we ready to face the challenges?

Ochoa de Olza, M. ; Oliva, M. ; Hierro, C. ; Matos, I. ; Martin-Liberal, J. ; Garralda, E.

Annals of oncology, 2018-08, Vol.29 (8), p.1727-1740 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

7
FLOT versus ECF/ECX peri-operative regimens in real life setting for patients with resectable gastric adenocarcinoma
Material Type:
Artigo
Adicionar ao Meu Espaço

FLOT versus ECF/ECX peri-operative regimens in real life setting for patients with resectable gastric adenocarcinoma

Graça, J. ; Pinto, M. ; Alberca, D. ; Chitonho, P. ; Matos, A. ; Barata, J. ; Neves, M. ; Alves, F. ; Martins, A.

Annals of oncology, 2019-07, Vol.30, p.iv69-iv69 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

8
Early-drug development in the era of immuno-oncology: are we ready to face the challenges?
Material Type:
Artigo
Adicionar ao Meu Espaço

Early-drug development in the era of immuno-oncology: are we ready to face the challenges?

Ochoa de Olza, M.O. ; Oliva, M. ; Hierro, C. ; Matos, I. ; Martin-Liberal, J. ; Garralda, E.

Annals of oncology, 2019-10, Vol.30 (10), p.1670-1670 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

9
Gemcitabine-based chemotherapy after FOLFIRINOX: a Portuguese retrospective multicenter analysis
Material Type:
Artigo
Adicionar ao Meu Espaço

Gemcitabine-based chemotherapy after FOLFIRINOX: a Portuguese retrospective multicenter analysis

Neves, M. ; Alves, F. ; Barata, J. ; Graça, J. ; Matos, A. ; Eiriz, I. ; Vitorino, M. ; Nogueira-Costa, G. ; Coelho, A. ; Pinto, M. ; Martins, A.

Annals of oncology, 2019-07, Vol.30, p.iv91-iv91 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

10
1521P Polypharmacy and therapeutic futility in patients near the end of life
Material Type:
Artigo
Adicionar ao Meu Espaço

1521P Polypharmacy and therapeutic futility in patients near the end of life

Graca, J.A. ; Matos, A.L.V. ; Barata, J. ; Fernandes, L. ; Pinto, M.M. ; Martins, A.

Annals of oncology, 2020-09, Vol.31, p.S937-S937 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Resultados 1 2 3 4 5 next page

Buscando em bases de dados remotas. Favor aguardar.